Tower Research Capital LLC (TRC) - CITIUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,214
+4.1%
16,394
+82.7%
0.00%
Q2 2023$10,7688,974
+1511.1%
0.00%
Q4 2022$0
-100.0%
557
-86.0%
0.00%
Q3 2022$5,000
-58.3%
3,979
-40.4%
0.00%
Q1 2022$12,000
-29.4%
6,678
-41.3%
0.00%
Q4 2021$17,000
-10.5%
11,373
+21.3%
0.00%
Q3 2021$19,000
-45.7%
9,375
-7.1%
0.00%
-100.0%
Q2 2021$35,000
-61.1%
10,096
-80.0%
0.00%
-50.0%
Q1 2021$90,000
+900.0%
50,356
+497.2%
0.00%
Q3 2020$9,000
-71.0%
8,432
-69.6%
0.00%
-100.0%
Q2 2020$31,00027,7200.00%
Q4 2017$000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Key Bridge Compliance, LLC 154,130$105,4870.03%
CHELSEA COUNSEL CO 81,300$55,6420.03%
Inspire Advisors, LLC 186,410$127,5790.02%
Horst & Graben Wealth Management LLC 75,722$51,8240.01%
GSA CAPITAL PARTNERS LLP 198,492$1360.01%
Arkadios Wealth Advisors 100,000$68,4400.01%
Miller Investment Management, LP 50,000$34,2200.01%
XTX Topco Ltd 29,077$19,9000.00%
Measured Wealth Private Client Group, LLC 10,000$6,8440.00%
Pasadena Private Wealth, LLC 10,965$7,5040.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders